H eme oxygenase (HO) catalyzes the reaction for heme metabolism, yielding equimolar quantities of CO, iron, and biliverdin. 1 The HO system consists of 2 isoforms: oxidative stress-inducible HO-1 (H mox-1 ), also known as heat-shock protein (HSP) 32, and the constitutive isozyme HO-2. 2 In addition to oxidants, a variety of other environmental stresses, including heat stress, hypoxia, metals, endotoxin, and certain hormones, can induce H mox-1 . 3, 4 Recent evidence suggests that H mox-1 induction plays a role in cellular protection against injury caused by the reactive oxygen species (ROS). 5 Enhancement of HO activity by endotoxin attenuated renal failure, and this protection was lost when HO was inhibited with protoporphyrin. 6 In another study, H mox-1 mediated an adaptive response to oxidative stress in skin fibroblasts. 7 ROS produced in the ischemic/reperfused myocardium has been shown to induce H mox-1 gene expression. 8 The physiological significance of H mox-1 induction during myocardial ischemia remains unknown. It seems reasonable to speculate that H mox-1 induction during ischemia/reperfusion is the heart's own stress signal for survival against oxidative stress.
Although a role of H mox-1 in myocardial protection has been speculated upon, a definitive cardioprotective role of H mox-1 is lacking. To fill this gap, we developed an H mox-1 ϩ/Ϫ mouse by targeted disruption of the mouse H mox-1 gene. The isolated hearts with 1 functional copy of the H mox-1 gene and those of matched wild-type mice were subjected to ischemia/reperfusion. To examine whether H mox-1 plays a role in stress adaptation, the hearts were subjected to preconditioning by cyclic episodes of ischemia/reperfusion. The results demonstrated impaired ventricular recovery and increased infarct size for the H mox-1 ϩ/Ϫ hearts compared with those from wild-type controls, suggesting that H mox-1 ϩ/Ϫ hearts are vulnerable to ischemia/reperfusion injury. Improvement of cardiac function was less apparent for the H mox-1 ϩ/Ϫ mice after preconditioning.
Methods Targeted Disruption of the Mouse H mox-1 Gene
As shown in Figure 1 , the XhoI fragment of the mouse H mox-1 gene 9 spanning from part of exon 1 to intron 2 was cloned into the XhoI site of the targeting vector pPNT. 10 The 3Ј XbaI-EcoRI fragment of the gene-containing sequence of intron 3 to 3Ј flanking region of the gene was subcloned into the corresponding XbaI and EcoRI sites in pPNT. The targeting vector was linearized with NotI digestion and then transfected into R1 embryonic stem (ES) cells 11 by electroporation. Five homologous recombinant ES clones were identified from 224 clones by DNA blot analysis using the 5Ј external probe encompassing sequences from nucleotide Ϫ133 to ϩ73. Male chimeric mice, generated by microinjecting C57BL/6 blastocytes with 3 independent clones, were used in breeding with C57BL/6 female mice. Germ-line transmission of 129/Sv chromosomes was achieved by chimeric mice derived from each of the homologous recombinant ES clones. Line 183 H mox-1 ϩ/Ϫ mice were used in this study.
Protein Blot Analysis of H mox-1 in Hearts
Hearts were homogenized in 50 mmol/L phosphate buffer, pH 7.8, containing 0.1% Triton X-100 with a Polytron homogenizer. The homogenates were centrifuged at 20 000g and stored at Ϫ70°C. Protein contents were determined with an assay kit (Pierce).
For protein blot analysis, total cellular protein was separated on a 12% SDS-polyacrylamide gel and electrophoretically transferred onto a nitrocellulose paper. The protein blot filter paper was incubated in 1ϫ HBSS plus a 1:2000 dilution of a monoclonal anti-human H mox-1 antibody (StressGen) for 2 hours. The filter paper was washed with HBSS containing 1% nonfat milk, incubated with a 1:3000 dilution of horseradish peroxidase-conjugated goat antimouse IgG (Bio-Rad, Hercules) in HBSS plus 5% nonfat milk for 1 hour, washed again with HBSS, and then subjected to autoradiography in the presence of an enhanced chemiluminescent substrate (Pierce). Western blot data were quantified by densitometric scanning.
Measurement of Contractile Function
Twenty-four mice (10 to 12 weeks old) were divided into 2 groups: H mox-1 ϩ/Ϫ (nϭ12) and wild-type (nϭ12). They were anesthetized with pentobarbital (200 mg/kg). The heart was excised, the aorta cannulated, and the heart perfused with Krebs-Henseleit buffer (KHB) by the Langendorff method. 12 The effluent was collected before ischemia and during reperfusion and stored at Ϫ20°C for subsequent measurement of creatine kinase (CK) and malondialdehyde (MDA). A 4-0 silk suture on a round-bodied needle was passed through the apex of the heart and attached to the apex, which in turn was attached to a force transducer. The heart rate, force developed by the heart (DF), and first derivative of developed force (dF/dt) were recorded. 12 The data on myocardial contractile function were recorded and analyzed in real time with the Cordat II data acquisition and presentation system (Triton Technologies). The hearts were subjected to 30 minutes of ischemia by clamping of the aortic cannula, followed by 2 hours of reperfusion.
Antioxidant Therapy
To examine whether antioxidants could protect the H mox-1 ϩ/Ϫ hearts from ischemia/reperfusion injury, 2 different protocols were used.
(1) For in vivo studies, both wild-type and H mox-1 ϩ/Ϫ mice were injected once every 24 hours with either Trolox (10 mg/kg IV), an analogue of vitamin E, or N-acetylcysteine (NAC, 1.5 mg/kg IV), a precursor of glutathione synthesis and an antioxidant. Control hearts were injected with saline only. (2) In vitro experiments were performed by preperfusion of the isolated wild-type and H mox-1 ϩ/Ϫ hearts for 15 minutes with KHB buffer in the presence or absence of Trolox (10 mmol/L) or NAC (10 mmol/L). All hearts were subjected to 30 minutes of ischemia followed by 2 hours of reperfusion. The cardioprotective abilities of the antioxidants were examined by study of ventricular function, infarct size, and CK release.
Preconditioning Protocol
Another group of hearts from H mox-1 ϩ/Ϫ and wild-type mice were preconditioned by subjection to 3 cycles of 5 minutes of ischemia each, followed by another period of 5 minutes of reperfusion. 13, 14 This preconditioning protocol has been found to render the heart tolerant to the subsequent ischemic stress. All hearts were subjected to 30 minutes of ischemia followed by 2 hours of reperfusion.
Estimation of CK Release
CK release from the heart was estimated in the perfusate collected from the heart by use of a CK assay kit (Sigma). The results are expressed as IU/L of total CK release from the heart. 
Estimation of MDA
MDA was assayed in the coronary perfusate as described previously 15 to monitor the development of oxidative stress. The MDA was derivatized with DNPH. 15 Aliquots of 25 L of derivatized MDA in acetonitrile were injected onto a Beckman Ultrasphere C 18 (3-mm) column in a Waters high-performance liquid chromatograph (Waters Corp). The products were eluted isocratically and detected at 307, 325, and 356 nm. The amount of MDA was quantified by use of a Maxima software program (Waters).
Measurement of Infarct Size
At the end of reperfusion, a 10% (wt/vol) solution of triphenyl tetrazolium in phosphate buffer was infused into the aortic cannula. 16 The hearts were excised and stored at Ϫ70°C. Sections (0.8 mm) of frozen heart were fixed in 2% paraformaldehyde, placed between 2 coverslips, and digitally imaged with a Microtek ScanMaker 600z. To quantify the areas of interest in pixels, an NIH Image 5.1 (a public-domain software package) was used. The infarct size (transmural) was quantified in pixels.
Statistical Analysis
For statistical analysis, a 2-way ANOVA followed by Scheffé's test was first carried out to test for any differences between groups. If differences were established, the values were compared by Student's t test for paired data. The values were expressed as meanϮSEM. The results were considered significant at a level of PϽ0.05.
Results

Generation and Characterization of H mox-1 ؉/؊ Mice
As shown in Figure 1a , the mouse H mox-1 gene was inactivated by replacement of exon 2 with a neomycin resistance (neo) cassette. Insertion of the neo gene creates a new PstI restriction site in the H mox-1 gene, resulting in a shorter PstI genomic fragment from the targeted allele than that from the wild-type allele (Figure 1b) . Heterozygous H mox-1 ϩ/Ϫ mice were apparently healthy and showed no pathological or phenotypic differences from the wild-type littermates. No homozygous knockout mice could be detected in the progeny from heterozygote intercross, however, indicating that embryonic lethality occurs in the homozygous mice. A 40% reduction of H mox-1 was evident in the heart of the heterozygous mouse compared with that of the wild-type mouse (Figure 1c) . We reasoned that a decrease in expression of H mox-1 protein due to the targeted mutation in H mox-1 ϩ/Ϫ mice might render the mice more susceptible to an increased oxidative stress than controls.
Myocardial Performance
All hearts recovered their beats spontaneously after 30 minutes of ischemia. The heart rates remained slightly but not significantly lowered, however, compared with baseline (results not shown). No significant difference was found in heart rate between groups throughout the experiment. Coronary flow progressively lowered during the reperfusion, but differences were not significant ( Figure 2 ). The DF during reperfusion was lower for the H mox-1 ϩ/Ϫ mouse hearts than wild-type hearts (Figure 3, top) . In control hearts, DF recovered to near baseline levels after 90 minutes of reperfusion. Conversely, DF did not recover beyond 87% of baseline for the H mox-1 ϩ/Ϫ hearts. At all points, DF showed significantly lower recovery for H mox-1 ϩ/Ϫ hearts than wild-type hearts after 30 minutes of reperfusion (PϽ0.05). A similar trend was seen in dF/dt max (Figure 3, bottom) . A significantly lower recovery of dF/dt max occurred in H mox-1 ϩ/Ϫ hearts after 30 minutes of reperfusion (PϽ0.05). These results demonstrate that H mox-1 ϩ/Ϫ mouse hearts showed significantly lower contractile recovery after 30 minutes of ischemia.
Preconditioning rendered the hearts of the wild-type mice tolerant to ischemia/reperfusion injury, as evidenced by improved DF and dF/dt compared with wild-type hearts not subjected to preconditioning. In contrast, the preconditioned hearts of the H mox-1 mice did not exhibit similar improvement in functional recovery, and there were no significant differences of DF and dF/dt between preconditioned and nonpreconditioned hearts.
Both in vivo and in vitro, Trolox and NAC treatments partially improved the contractile function. For example, (Table) . Interestingly, both antioxidants (in vivo or in vitro) improved DF and dF/dt to the same extent. Baseline values of the antioxidant-treated (in vivo or in vitro) and untreated groups were identical.
CK Release From Heart
Total CK release from the heart (Figure 4 ) was negligible for all the groups before ischemia. After ischemia, CK release increased in both groups, but the amount of release was much higher for H mox-1 ϩ/Ϫ hearts. At 30 minutes of reperfusion, CK release was 70Ϯ9.7 IU/mL for H mox-1 ϩ/Ϫ mice versus 50Ϯ11.5 IU/mL (PϽ0.05) for nontransgenic controls. At 60 minutes of reperfusion, CK release was 120Ϯ8.7 IU/mL for H mox-1 ϩ/Ϫ hearts versus 82Ϯ9.4 IU/mL (PϽ0.05) for nontransgenic controls. Similarly, after 120 minutes of reperfusion, CK release from the knockout mouse hearts amounted to 239Ϯ8.1 IU/mL compared with 135Ϯ7.4 IU/mL for controls.
Preconditioning significantly reduced the amount of CK in wild-type hearts compared with the nonpreconditioned group. The amount of CK release was also less for the preconditioned H mox-1 ϩ/Ϫ hearts than for nonpreconditioned hearts, but the differences did not reach significance except at 90 and 120 minutes of reperfusion.
In vivo and in vitro, Trolox and NAC treatments partially but significantly reduced the CK release compared with that from the H mox-1 ϩ/Ϫ hearts (Table) . Again, both antioxidants reduced the CK release to the same extent. Baseline values of the antioxidant-treated and untreated groups were identical.
Myocardial Infarction
The portion of the heart not stained by tetrazolium was measured and calculated as the infarct area. Mean value of infarct size in the knockout group was significantly higher than that in the wild-type group (48.5Ϯ3.2% versus 28.5Ϯ2.4% for wild-type, PϽ0.05) ( Figure 5 ). Our results indicated that H mox-1 ϩ/Ϫ hearts had significantly higher myocardial necrosis.
A reduced amount of infarct size was apparent in the hearts subjected to preconditioning. Significantly less infarct was noticed, however, for the preconditioned wild-type hearts than nonpreconditioned hearts.
Both in vivo and in vitro, Trolox and NAC treatments partially but significantly reduced the infarct size compared with the H mox-1 ϩ/Ϫ hearts (Table) . Similar to the previous results, both antioxidants reduced the infarct size to the same extent.
Effects of Dimethylthiourea and NAC on Ventricular Function and Myocardial Infarct
MDA Formation
MDA, measured as MDA-DNPH, increased progressively during reperfusion for the nonpreconditioned hearts (Figure 6 ). The amount of MDA production, however, was significantly higher at all points in the H mox-1 ϩ/Ϫ hearts than in control hearts, demonstrating that H mox-1 ϩ/Ϫ hearts were subjected to increased amounts of oxidative stress. Preconditioning reduced the amount of MDA formation in both groups of hearts. A significantly higher amount of MDA was found in the H mox-1 hearts than in the wild-type control hearts.
Discussion
As mentioned earlier, H mox-1 ϩ/Ϫ mouse hearts showed Ϸ40% reduction of H mox-1 protein compared with H mox-1 ϩ/ϩ hearts. The activities of other key antioxidant enzymes, including manganese superoxide dismutase (Mn-SOD), catalase, glutathione peroxidase, glutathione reductase, and glucose-6-phosphate-dehydrogenase, remained unaltered in the H mox-1 ϩ/Ϫ hearts compared with wild-type controls (data not shown). The results thus truly reflect the effects of H mox-1 ϩ/Ϫ in myocardial ischemia/reperfusion injury.
H mox-1 ϩ/Ϫ hearts were more susceptible to ischemia/ reperfusion injury, as evidenced by greater infarct size, increased CK release, and reduced ventricular recovery compared with wild-type controls. In addition, these H mox-1 ϩ/Ϫ hearts could not be preconditioned like the hearts of the wild-type controls, suggesting that H mox-1 plays a role in the adaptation to stress. This is further supported by the results with MDA, because MDA formation, a presumptive marker for oxidative stress, was higher for the preconditioned H mox-1 ϩ/Ϫ mouse hearts than the wild-type hearts. During the course of our studies, Poss and Tonegawa 17, 18 have reported generation of H mox-1 ϩ/Ϫ mice in which exons 3, 4, and part of 5 were replaced by the neo cassette. Whereas they were able to obtain homozygous knockout mice from heterozygous breeding at a lower-than-expected frequency, an indication of embryonic lethality due to H mox-1 deficiency, we could not detect any homozygous knockout mice in our breeding colony. The discrepancy in our breeding results is not understood. It may result from the fact that different ES cells were being used in each laboratory. The studies by Poss and Tonegawa using homozygous knockout mice have clearly established the antioxidant role of H mox-1 against the toxicity resulting from treatment with endotoxin, heme, and hydrogen peroxide. We rationalized that a modest decrease in H mox-1 gene expression in H mox-1 ϩ/Ϫ hearts might also cripple the cellular antioxidant defense mechanism, which is protective in certain disease models whose pathogenesis is known to be associated with an overproduction of ROS. Similar to what was observed by Poss and Tonegawa, 18 the H mox-1 ϩ/Ϫ mice generated in our laboratory showed no increased susceptibility to endotoxin toxicity compared with that of wild- Heme oxygenase, which catalyzes the initial ratelimiting step of heme catabolism, is known to be induced by a wide variety of oxidative stresses, including H 2 O 2 , UV radiation, and reduced glutathione depletion. 3, 4 A study from our laboratory documented that ischemia/reperfusion could induce the expression of H mox-1 mRNA in the heart. 8 Induction of H mox-1 gene expression increased as a function of duration of reperfusion, which could be inhibited with ROS scavengers and SOD, suggesting that oxidative stress developed during ischemia/reperfusion induces the HO-1 gene. Our results are consistent with these previous reports, indicating that H mox-1 is induced by oxidative stress.
The role of HO-1 in oxidative stress adaptation was further supported by the observation that the hearts of the H mox-1 ϩ/Ϫ mice could not be preconditioned to make them resistant to subsequent oxidative stress compared with wild-type hearts. Preconditioning by repeated brief episodes of ischemia/reperfusion is known to develop oxidative stress. 19 The development of oxidative stress presumably leads to adaptive modification of the hearts, which is achieved through a chain of reactions including generation of intracellular mediators and modification of signal transduction processes and gene expression. 20 Oxidative stress has been shown to function as a second messenger in this process. 21 The results of our study suggest that induction of HO-1 by oxidative stress plays a crucial role in preconditioning-mediated adaptive modification of the heart.
HO, an oxidative stress-inducible protein, is also an HSP, HSP 32. HO-1 is evolutionarily conserved in the primary amino acid and nucleotide sequences, and its extent of homology between mouse, rat, and human is Ͼ80%. H mox-1 is readily induced not only by oxidative stress but also with many other pathological and environmental stresses, such as hypoxia, hyperoxia, cellular transformations, and heat shock. 22 This enzyme catalyzes the conversion of heme into biliverdin and bilirubin, which function as in vivo antioxidants. 1 In addition, a messenger molecule, carbon monoxide (CO), is generated during the production of biliverdin. Previous studies demonstrated that production of cGMP from CO signaling is beneficial for the heart. 23 To examine whether antioxidants could rescue the H mox-1 ϩ/Ϫ hearts from increased ischemia/reperfusion injury, the H mox-1 ϩ/Ϫ mice were treated with 2 different antioxidants, Trolox and NAC. Both of these antioxidants are cell-permeable. Trolox, an analogue of vitamin E, is a hydrophilic antioxidant that has been found to be cardioprotective. NAC is a precursor of glutathione and functions as an antioxidant. NAC also prevents intracellular oxidation and maintains glutathione levels by reducing cystine to cysteine. Both Trolox and NAC provided similar degrees of cardioprotection when used in vitro or in vivo. Neither of these antioxidants, however, could completely rescue the hearts from the ischemia/reperfusion injury. Nevertheless, they significantly reduced the amount of ischemia/reperfusion injury compared with control H mox-1 ϩ/Ϫ hearts. Interestingly, the amount of cardioprotection afforded by these antioxidants was comparable to that obtained by preconditioning the H mox-1 ϩ/Ϫ hearts. Numerous reports in the literature indicate cardioprotective effects of preconditioning. 24, 25 Preconditioning potentiates a signal transduction mechanism coupled with both G-protein and tyrosine kinase receptors, leading to the activation of protein kinase C and mitogen-activated protein kinases and redox-sensitive transcription factors such as nuclear factor-B and activating protein-1. 26 Preconditioning-mediated cardioprotection is believed to be achieved through its ability to induce several cardioprotective genes and proteins, including HSP 27, HSP 70, HSP 89, SOD, and reduced glutathione peroxidase-1. 27 These genes/proteins have been shown to constitute the defense system of the myocardium. Our results demonstrate that HO-1 is also an important member of the antioxidant defense system of the heart. In summary, our study documents the crucial role of H mox-1 in cardioprotection. A decrease in HO-1 in the heart makes it vulnerable to ischemia/reperfusion injury. In vivo or in vitro antioxidant therapy only partially rescued the H mox-1 ϩ/Ϫ hearts from the ischemia/reperfusion injury, suggesting that HO-1 plays an important role in cardioprotection. Preconditioning, which provokes oxidative stress and induces a large variety of oxidative stress-inducible genes, was unable to rescue the hearts of heterozygous H mox-1 ϩ/Ϫ mice from cellular injury, presumably because of the reduced level of H mox-1 . This paves the way for the potential of H mox-1 gene therapy for cardioprotection in pathological conditions in which oxidative stress is implicated.
